These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 35245354)

  • 1. Comment on Fahrmann et al. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2021;44;2132-2139.
    González-Clemente JM; Llauradó G; Romero A; Giménez-Palop O; Berlanga E; Vendrell J
    Diabetes Care; 2022 Mar; 45(3):e63-e64. PubMed ID: 35245354
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Comment on Fahrmann et al. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2021;44;2132-2139.
    Fahrmann ER; Driscoll HK
    Diabetes Care; 2022 Mar; 45(3):e65-e66. PubMed ID: 35245357
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study.
    Fahrmann ER; Adkins L; Driscoll HK
    Diabetes Care; 2021 Sep; 44(9):2132-2139. PubMed ID: 34233927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
    Purnell JQ; Zinman B; Brunzell JD;
    Circulation; 2013 Jan; 127(2):180-7. PubMed ID: 23212717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
    DCCT/EDIC research group
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):793-800. PubMed ID: 25043685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657-664.
    Snaith JR; Holmes-Walker DJ; Greenfield JR
    Diabetes Care; 2019 Aug; 42(8):e135-e136. PubMed ID: 31332031
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657-664.
    Braffett BH; Dagogo-Jack S; Bebu I; Sivitz WI; Larkin M; Kolterman O; Lachin JM;
    Diabetes Care; 2019 Aug; 42(8):e137. PubMed ID: 31332032
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
    Pop-Busui R; Low PA; Waberski BH; Martin CL; Albers JW; Feldman EL; Sommer C; Cleary PA; Lachin JM; Herman WH;
    Circulation; 2009 Jun; 119(22):2886-93. PubMed ID: 19470886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of the study coordinator role: the 28-year experience in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).
    Larkin ME; Lorenzi GM; Bayless M; Cleary PA; Barnie A; Golden E; Hitt S; Genuth S
    Clin Trials; 2012 Aug; 9(4):418-25. PubMed ID: 22729476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.
    ; Orchard TJ; Nathan DM; Zinman B; Cleary P; Brillon D; Backlund JY; Lachin JM
    JAMA; 2015 Jan; 313(1):45-53. PubMed ID: 25562265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.
    Am J Med; 1991 Apr; 90(4):450-9. PubMed ID: 2012085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus.
    Sousa GR; Pober D; Galderisi A; Lv H; Yu L; Pereira AC; Doria A; Kosiborod M; Lipes MA
    Circulation; 2019 Feb; 139(6):730-743. PubMed ID: 30586738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).
    Basu A; Jenkins AJ; Zhang Y; Stoner JA; Klein RL; Lopes-Virella MF; Timothy Garvey W; Lyons TJ;
    Data Brief; 2016 Mar; 6():33-8. PubMed ID: 26759826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathy in the DCCT/EDIC-What Was Done Then and What We Would Do Better Now.
    Pop-Busui R; Martin C
    Int Rev Neurobiol; 2016; 127():9-25. PubMed ID: 27133142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
    Van Den Eeden SK; Sarma AV; Rutledge BN; Cleary PA; Kusek JW; Nyberg LM; McVary KT; Wessells H;
    Diabetes Care; 2009 Apr; 32(4):664-70. PubMed ID: 19171725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of risk assessment models for diabetes-related complications based on the DCCT/EDIC data.
    Lagani V; Chiarugi F; Thomson S; Fursse J; Lakasing E; Jones RW; Tsamardinos I
    J Diabetes Complications; 2015; 29(4):479-87. PubMed ID: 25772254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coprogression of Cardiovascular Risk Factors in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study.
    Writing Group for the DCCT/EDIC Research Group
    Diabetes Care; 2016 Sep; 39(9):1621-30. PubMed ID: 27436274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Realising the long-term promise of insulin therapy: the DCCT/EDIC study.
    Nathan DM
    Diabetologia; 2021 May; 64(5):1049-1058. PubMed ID: 33550441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2017;40:1010-1016.
    Gubitosi-Klug RA; Braffett BH; White NH; Sherwin RS; Service FJ; Lachin JM; Tamborlane WV;
    Diabetes Care; 2021 Jan; 44(1):298. PubMed ID: 33158952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.